BioSpace News Archive

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that it will be presenting at the 12th annual LD 500 conference on Tuesday, September 1, at 11:00 AM ET.

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA, today announced a collaborative agreement with Mass General Cancer Center (MGCC) of Massachusetts General Hospital, related to an investigator-initiated multi-center, Phase II randomized clinical trial of Ribociclib (Kisqali®),

Battelle continues its work helping the nation develop and validate quantifiable assurance tools and approaches mitigating the threat of counterfeit and untrustworthy integrated circuits and embedded system in the military’s supply chain.

Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company, today announced that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will give a virtual corporate presentation at the LD 500 Virtual Conference on Wednesday, September 2, 2020 at 1:20 pm ET, Track 2, followed by a live Q&A session with registered investors and other conference attendees.

PAVmed Inc. today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3, 2020 at 7:20 a.m. PST / 10:20 a.m. EST.

Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax ® personalized immune therapies for solid tumor cancers, today announced that the Company is pursuing an intensive program of

InVita Healthcare Technologies, a leading software technology provider for complex medical environments, is offering expedited startup and deferred payment for its HemaConnect donor recruitment CRM.

Vitanova Biomedical (VNB), the San Antonio, Texas-based biotechnology company dedicated to improving the lives of cancer patients and the healthcare professionals who care for them, has been awarded a National Science Foundation (NSF) SBIR grant for $225,000 to conduct research and development (R&D)

LSNE Contract Manufacturing, a leading contract development and manufacturing organization, is pleased to announce that the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved the manufacturing of clinical

BioForward Wisconsin, the collective voice of Wisconsin’s robust and comprehensive biohealth cluster, representing more than 220 member organizations, will reflect the resilience of the Wisconsin biohealth industry by continuing to hold its annual Wisconsin Biohealth Summit, now in a virtual format over September 23, September 30, and October 7, 2020.